JB Chemicals & Pharmaceuticals (JBCPL) is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
Incorporated in 1976, the company is part of Unique Group. It has operational presence in more than 50 countries.
Headquartered at Mumbai, the company has 11 state-of-the-art manufacturing units located at Belapur, Panoli, Ankleshwar and Daman.
The company’s in-house research and development facilities conduct various activities such as developing of new product in therapeutic segments such as anti-diabetics, CNS and respiratory; development of niche technology and processes. JBCPL is engaged in making of lozenges and cough syrups enabling company to explore European markets.
The company also undertakes contract research and manufacturing services (CRAMS) for companies in US, Europe, Australia and South Africa.
JBCPL owns three subsidiaries namely J B Life Science Overseas (India), OOO Unique Pharmaceuticals Laboratories (Moscow, Russia) and J B Healthcare (Jersey, Channel Islands).
JBCPL exports to over 40 countries worldwide with a strong presence in Russia, Ukraine and the other CIS countries.
The company has created brands namely Doktor Mom, Metrogyl, Rantac and Nicardia.
2008 - Made a strategic investment in a company in South Africa called Biotech Laboratories.
In 2010 J.B.Chemicals received US FDA approval for Diclofenac Sodium Tablets and Supplemental information on US FDA approval for Diclofenac Sodium TabletsIn 2011 the company divested the OTC portfolio in Russia, Ukraine and CIS to J&J. The same year J.B.Chemicals launched a New Domestic DivisionProducts
Active Pharmaceutical Ingredients (APIs) - The company manufactures 8 APIs. It is one of the largest manufacturers of Diclofenac Sodium and Metronidazole.
Formulations - JBCPL is engaged in developing formulations in therapeutic segment such as diabetic, cardiovascular, urology, psychiatry, etc. The company is currently focusing on the lozenges segment.
The company is also engaged in manufacturing of bulk drugs.
The company’s Doktor Mom herbal brand was voted as 'Europe's Most Trusted Brand' in the Readers Digest Magazine 2007 Survey for the seventh successive year in the cold and cough remedies segment.
JBCPL's Annual Report for the year ended 31st March, 2005 has been awarded a Merit certificate by the South Asian Federation of Accountants (SAFA), an apex body of SAARC, for the Best Presented Accounts for the year 2005 in the category of 'Hospitality, Health, Transport, Shipping, etc'.